Concepedia

Publication | Open Access

An Open-Label Study of Nefazodone Treatment of Major Depression in Patients with Congestive Heart Failure

37

Citations

29

References

2003

Year

Abstract

It is feasible to screen and recruit CHF patients with major depression for an anti-depressant trial. Nefazodone seems sufficiently safe, tolerable, and efficacious to justify a larger, placebo-controlled trial.

References

YearCitations

Page 1